Healthcare Tech

Before the pandemic, most people had never heard of Illumina, the California-based sequencing behemoth whose machines generate upwards of 90% of the world’s DNA data. And while Illumina might still not be a household name, over the last 15 months the technology it sells has become standard dinner table fare. Genetic vaccines, coronavirus variants, wastewater
0 Comments
Health tech startup Cityblock Health, with its mission of delivering stepped-up primary care to Medicaid patients, is finding its footing in the very cracks that the Covid-19 pandemic has exposed. It’s leveraging its signature technology to help this highly marginalized population. “It’s very telling here that up until before the pandemic, there was a real
0 Comments
Kylene Redmond and Deb Foerster both are converts to their continuous glucose monitors, quarter-size devices that measure their blood sugar in real time so they can adjust their diet, their activity, and the medications they take to manage their diabetes. The automated sensors give both women feedback they can use to better control their disease
0 Comments
Amazon’s objectives for its nascent pharmacy business are straightforward: “better selection, better convenience, and better prices,” according to TJ Parker, the vice president of pharmacy at the company. “It really is the Amazon playbook,” he said during a Wednesday panel at STAT’s Health Tech Summit. Unlock this article by subscribing to STAT+ and enjoy your
0 Comments
WASHINGTON — Telehealth companies, flush with cash after the Covid-19 pandemic spiked both demand and investment, are now embarking on massive lobbying efforts to secure their interests on Capitol Hill. The goal is clear: Lawmakers are weighing whether to permanently loosen regulations that were temporarily eased during the pandemic. Among other changes, providers have been
0 Comments
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science
0 Comments
Dyno Therapeutics, a Cambridge biotech that uses artificial intelligence techniques to develop gene therapies, said Thursday that it has raised $100 million from investors. The company uses machine learning to design a type of gene therapy “vector,” or carrier, aiming to make treatments that are easier to deliver and more effective. Dyno said the funding would
0 Comments
A $1 million government contest to predict health problems with artificial intelligence attracted the heavyweights of industry and beyond — from Mayo Clinic, to IBM, to the data and consulting powerhouse Deloitte. But the winner of Medicare’s AI health outcomes challenge is a lesser-known startup from Austin, Texas, called ClosedLoop.ai. The company, whose victory was
0 Comments